7TM Pharma AS, a Danish drug company focused on metabolic disorders, has raised around $22 million in fourth-round funding. S.R. One Ltd. led the deal, and was joined by return backers Alta Partners, Baker/Tisch Investments, Dansk Innovationsinvestering, Index Ventures, Johnson & Johnson Development Corp., LD Pensions, Lombard Odier Darier Hentsch,
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.